首页> 外文期刊>Animal Biotechnology >Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain
【24h】

Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain

机译:在骨骼肌中同时表达生长激素释放激素(GHRH)和乙型肝炎表面抗原/生长抑素(HBsAg / SS)融合基因可增强兔子的体重

获取原文
获取原文并翻译 | 示例
           

摘要

Somatostatin (SS) and growth hormone-releasing hormone (GHRH) are synthesized and secreted by the hypothalamus, which can control the synthesis and secretion of the growth hormone (GH) from the hypophysis as well as regulate the GH concentrations in animals and humans. In this article, we describe the regulation of animal growth using plasmid DNA encoding both the GHRH gene and the SS gene fused with the hepatitis B surface antigen (HBsAg) gene. We constructed a series of expression plasmids to express the GHRH and HBsAg-SS fusion genes individually as well as collectively. The fusion gene and GHRH were successfully expressed in Chinese hamster ovary (CHO) cells, as proven by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblotting tests. Poly D, L-lactide-co-glycolic acid (PLGA) plasmid-encapsulating microspheres were prepared and injected intramuscularly into the leg skeletal muscles of rabbits. Weight gain/day and the levels of insulinlike growth factor-I (IGF-I), SS, and hepatitis B surface antibody (HBsAb) were monitored. During days 30 postinjection, increase in weight gain/day and IGF- I concentration and decrease in SS were observed in treatment groups. From days 15 to 30 postinjection, the weight gain/day significantly increased (P < 0.05) by 129.13%, 106.8%, and 72.82% relative to the control group in the co-expression GHRH and fusion gene (named P-G-HS), fusion gene (named P-HS), and GHRH (named P-G) groups, respectively. And most importantly, the P-G-HS group showed significant weight gain/day (P < 0.05) relative to the P-G and P-HS groups. A significant increase in the IGF-I concentration and decrease in the SS level relative to the control group were also observed. The results indicated that the combination of plasmid-mediated GHRH supplementation and positive immunization against SS led to more robust weight gain/day in rabbits.
机译:下丘脑合成和分泌生长抑素(SS)和生长激素释放激素(GHRH),下丘脑可控制来自垂体的生长激素(GH)的合成和分泌,并调节动物和人类的GH浓度。在本文中,我们描述了使用编码GHRH基因和与乙型肝炎表面抗原(HBsAg)基因融合的SS基因的质粒DNA调节动物生长的过程。我们构建了一系列表达质粒,分别或共同表达GHRH和HBsAg-SS融合基因。逆转录酶-聚合酶链反应(RT-PCR)和免疫印迹测试证明,该融合基因和GHRH在中国仓鼠卵巢(CHO)细胞中成功表达。制备了聚D,L-丙交酯-共乙醇酸(PLGA)质粒包裹的微球,并将其肌肉注射到兔的腿骨骼肌中。监测每天的体重增加和胰岛素样生长因子-I(IGF-I),SS和乙型肝炎表面抗体(HBsAb)的水平。在注射后第30天,在治疗组中观察到体重增加/天和IGF-I浓度增加和SS减少。从注射后第15天到第30天,在共表达GHRH和融合基因(称为PG-HS)中,每天的体重增加比对照组显着增加(P <0.05)129.13%,106.8%和72.82%,融合基因(命名为P-HS)和GHRH(命名为PG)组。最重要的是,相对于P-G和P-HS组,P-G-HS组的体重增加/天(P <0.05)。相对于对照组,还观察到IGF-I浓度显着增加和SS水平降低。结果表明,质粒介导的GHRH补充和针对SS的阳性免疫相结合,可使兔的日增重更为稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号